The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design.

@article{Bax2003TheBO,
  title={The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design.},
  author={Liesbeth Bax and W. P. Th. M. Mali and Erik Buskens and Hein A. Koomans and Jaap J. Beutler and Branko Braam and Frederik J. A. Beek and Ton J Rabelink and Cornelis T. Postma and Frans Th M Huysmans and J. T. Deinum and T H Thien and Leo J Schultze Kool and Arend Jan Jacob Woittiez and J. J. Kouwenberg and Anton H. van den Meiracker and Peter M. T. Pattynama and Peter JG van de Ven and Dammis Vroegindeweij and Cornelius J Doorenbos and Johannes C N M Aarts and Abraham A. Kroon and Peter W de Leeuw and Michiel Willem de Haan and Jos M. A. van Engelshoven and Matthieu J. C. M. Rutten and Gert A. van Montfrans and Jim A. Reekers and Pierre-François Plouin and Agn{\`e}s La Batide Alanore and Michel Azizi and Alain Raynaud and Paul Neil Harden and Mark G. Cowling},
  journal={Journal of nephrology},
  year={2003},
  volume={16 6},
  pages={807-12}
}
BACKGROUND Atherosclerotic renal artery stenosis (ARAS) is associated with progressive loss of renal function and is one of the most important causes of renal failure in the elderly. Current treatment includes restoration of the renal arterial lumen by endovascular stent placement. However, this treatment only affects damage caused by ARAS due to the stenosis and ensuing post-stenotic ischemia. ARAS patients have severe general vascular disease. Atherosclerosis and hypertension can also damage… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…